Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3‐internal tandem duplication mutation–positive acute myeloid leukemia
暂无分享，去创建一个
H. Kantarjian | G. Garcia-Manero | J. Cortes | K. Patel | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | C. Dinardo | N. Pemmaraju | N. Short | S. Loghavi | S. Pierce | K. Sasaki | P. Bose | K. Naqvi | M. Yilmaz | I. A. Dalle | F. Yalniz